SREBF1 and metabolic dysfunction-associated steatohepatitis: Low-level expression of PPAR-α will induce the risk of NASH, which can be treated well by chicory (Cichoriumintybus L.)seed extract by affecting the level of PPAR-α [37] while PPAR-α activation will inhibit SREBP-1c pathway [38].